ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Promeza MG Expands Speaking Engagements Following Success of NDE Book by Critical Care Nurse

VALENCIA, CA - October 27, 2025 - PRESSADVANTAGE -

Promeza MG announces expanded speaking opportunities for author and registered nurse Raul Meza following the continued success of his book "Injection of Faith," which documents real-life stories from his 32 years of critical care experience, including accounts of Near Death Experience Stories from intensive care unit patients.

The book, which draws from three decades of medical experience in hospital intensive care units, has generated increased interest from both medical and faith-based communities across the United States and internationally. Meza now receives regular invitations to speak at nursing conferences and churches throughout the country, with recent speaking tours extending to Mexico and Argentina.

Injection of Faith

"Injection of Faith" presents documented accounts from the intensive care unit, where patients have shared their NDE's and other remarkable experiences during critical medical moments. The collection represents observations and patient testimonies gathered during Meza's extensive career as a critical care nurse, offering readers insights into the extraordinary events that can occur during life-threatening medical situations.

"The response to these real-life accounts has been overwhelming," said Betty Meza, representative for Promeza MG. "Medical professionals appreciate the clinical perspective combined with the human element, while faith communities find inspiration in the miraculous recoveries and spiritual experiences shared by patients. The book bridges the gap between medical science and matters of faith in a unique way."

The expanded speaking engagements reflect growing interest in the intersection of medical care and spiritual experiences. Nursing conferences have incorporated Meza's presentations as part of professional development programs, addressing both the clinical and emotional aspects of critical care nursing. Churches and faith-based organizations have welcomed his message as it provides documented accounts that resonate with their communities.

To accommodate diverse audiences, Promeza MG offers both English and Spanish versions of the book. The Spanish edition, titled "Inyección de Fe," has enabled Meza to connect with Spanish-speaking communities throughout the Americas. His bilingual capabilities have proven valuable as speaking invitations continue to arrive from various international locations.

The book's impact extends beyond traditional publishing metrics. Healthcare professionals have noted its value in understanding patient experiences during critical medical events, while individuals facing health challenges have found comfort and hope in the documented stories of recovery and transformation.

Promeza MG, through its publishing division Promeza Publishing, specializes in works that address the intersection of healthcare, faith, and human experience. The company focuses on bringing authentic stories from medical professionals to wider audiences, particularly those that offer hope and inspiration during challenging times. The success of "Injection of Faith" by Raul Meza represents the company's commitment to sharing meaningful narratives that resonate across professional and personal boundaries.

###

For more information about Promeza MG, contact the company here:

Promeza MG
Betty Meza
818-264-4123
info@promeza.com
27240 Turnberry Ln, Ste 200, Valencia, CA 91355

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.40
+3.99 (1.63%)
AAPL  269.43
+0.96 (0.36%)
AMD  243.98
+10.44 (4.47%)
BAC  53.42
+0.22 (0.41%)
GOOG  290.59
+10.89 (3.89%)
META  631.76
+10.05 (1.62%)
MSFT  506.00
+9.18 (1.85%)
NVDA  199.05
+10.90 (5.79%)
ORCL  240.83
+1.57 (0.66%)
TSLA  445.23
+15.71 (3.66%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.